Your Location：
Home >
Browse articles >
Diagnostic efficacy of fecal-based miR-92a for advanced colorectal neoplasia: a prospective multicenter screening trial
RESEARCH | Updated：2026-01-27

    • Diagnostic efficacy of fecal-based miR-92a for advanced colorectal neoplasia: a prospective multicenter screening trial

    • “In a prospective multicenter screening trial, miR-92a demonstrated better sensitivity, NNS, Youden index and AUC as compared with FIT for advanced colorectal neoplasia screening. Using miR-92a appears to be more efficient for population-based screening programs, and screening sensitivity can be further enhanced if conditionally used in combination with FIT.”
    • Military Medical Research   Vol. 12, Issue 11, Pages: 1722-1734(2025)

    • DOI：10.1186/s40779-025-00613-3    

      CLC：

    • Received：02 January 2025，

      Accepted：29 April 2025，

      Online First：13 June 2025，

      Published：2025-11

    Scan QR Code

  • Jia-Chen Wang, Li Zhao, Xiang-Yang Yu, et al. Diagnostic efficacy of fecal-based miR-92a for advanced colorectal neoplasia: a prospective multicenter screening trial[J]. Military Medical Research, 2025, 12(11): 1722-1734. DOI： 10.1186/s40779-025-00613-3.

  •  
  •  

0

Views

1

Downloads

0

CSCD

Alert me when the article has been cited
Submit
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Effectiveness and cost-effectiveness of risk-adapted colorectal cancer screening: a randomized controlled trial and modeling analysis
Molecular diagnostic approaches for enteric parasites: an issue of relevance for deployed soldiers?
Preparing for a "dirty bomb" attack: The optimum mix of medical countermeasure resources
Analysis on the Reason of Larger Wheel/Rail Lateral Force for Loaded Car with 3D-axle Welded-frame Bogies during Negotiating
Research on Wheel/Rail Action of Heavy Haul Train

Related Author

Hong-Hui Cheng
Xi-Mo Wang
Wei-Qing Wu
Wan-Qing Chen
Hong-Da Chen
Bin Lu
Ju-Fang Shi
Yue-Yang Zhou

Related Institution

German Cancer Con-sortium (DKTK), German Cancer Research Center (DKFZ)
Center for Prevention and Early Intervention, National Infrastructures for Translational Medicine, Institute of Clinical Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Department of Cancer Epidemiol-ogy, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Office of Cancer Screening, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Department of Cancer Prevention, Institute of Cancer and Basic Medicine (ICBM), Chinese Academy of Sciences, Cancer Hospital of University of Chinese Academy of Sciences, Zhejiang Cancer Hospital
0